EmbryoGlue During IVF in Delhi: What the Evidence and Invoice Should Tell You

Choosing an embryo-transfer culture medium is different from choosing whether to transfer an embryo. EmbryoGlue is a brand name for a hyaluronate-enriched medium used around transfer, not an adhesive that physically sticks an embryo to the uterus. For patients in Green Park, Delhi, the practical goal is to resolve the question using the existing medical record before committing to additional tests or procedures. A locality reference is for search relevance and patient planning; it is not a claim that HomeIVF operates a clinic there.

The word “glue” can create a very specific expectation: that an embryo otherwise might slip away and this medium prevents it. That is not how implantation works. The embryo must develop appropriately, the endometrium must be receptive and several biological events must align. Ask the embryologist what the medium contains, at what step it is used, and whether it replaces or supplements the laboratory’s usual transfer medium. An optional laboratory medium should never be presented as a guaranteed way to make pregnancy happen.

The UK HFEA currently describes conflicting moderate- or high-quality evidence for hyaluronate-enriched transfer media. That is a reason to discuss uncertainty, not an argument that all patients must buy it or that it never helps. The most useful evidence question is whether the clinic can explain evidence for people with a history like yours, using live birth as the outcome rather than a change in a laboratory score. Avoid taking a pooled research finding as your own predicted chance.

Ask whether the fee is included in the base package, offered as an optional line item or incorporated into the lab’s standard protocol without a separate choice. Request a written quote that distinguishes embryo culture, freezing, warming, transfer and any optional medium. Patients should be able to decline an optional add-on after informed discussion without being made to feel responsible for a possible failed cycle. Ask for the specific consent form and whether the quoted price is refundable if no transfer occurs.

Before booking an additional appointment, write down one question the test, procedure or consultation is intended to answer. Ask whether an existing report already answers it, whether timing or measurement makes that report unreliable and what the team would do with either a positive or negative result. A review that cannot change a decision may not justify another test.

If the proposed reason is a previous unsuccessful transfer, first review the embryo stage and quality, details of transfer, uterine cavity findings where indicated, relevant hormone timing, and whether a more basic cause is still unassessed. A different medium does not replace a complete review. When a clinic recommends an add-on only because several transfers have failed, ask what alternative explanations were ruled out and what data would change the recommendation.

An extra laboratory method or medicine should have its own purpose and informed-consent discussion. Ask whether the option is part of the centre’s ordinary validated pathway, a separately priced selection method, or a treatment being offered despite uncertain evidence. A change in embryo appearance, a laboratory score or a physiological marker does not automatically prove more live births. The comparator matters: what would happen using the standard approach without the add-on?

A useful appointment ends with one of three documented outcomes: use the centre’s usual medium, consider the optional medium with its limitations clearly explained, or defer the choice until the embryology plan is final. No new blood panel is required solely because a branded medium is being considered unless the treating team identifies a separate indication. Repeated tests and add-ons can escalate cost without clarifying the important treatment choice.

Ask for the standard-cycle quotation and a second version showing the additional technique separately. The estimate should state the stage at which the fee becomes payable, what happens if the procedure cannot be used, and whether the cost applies again in a later cycle. Record the medical rationale, expected benefit, plausible risk and level of evidence, rather than accepting an unqualified claim that modern technology guarantees better outcomes.

HomeIVF's intended model is doctor-led fertility care with fewer unnecessary clinic visits, not laboratory IVF at home. Depending on a clinician's instructions and verified local arrangements, an initial consultation, review of previous reports, selected home blood collection, medication or injection support, follow-up and care coordination may occur at or near home. Availability is conditional, not promised for this locality. The treating team must identify which results can be reviewed remotely and which require an in-person decision.

Ultrasound examinations, when required, need suitable imaging equipment and trained professionals. Egg retrieval, sperm preparation where relevant, fertilisation, embryo culture, cryostorage and embryo transfer require appropriate specialist facilities. Serious symptoms need in-person assessment, often urgently. No infographic or patient article should imply that eggs can be retrieved, embryos created or transfers performed in someone’s bedroom.

Before signing, ask the embryology team to define its normal transfer workflow and any patient-specific safety issues. Bring the proposed bill and your prior embryo report if there was a previous cycle. A doctor-led review can be started remotely, but laboratory selection and embryo transfer take place in regulated, appropriately equipped facilities. This guide does not confirm that any particular Delhi clinic uses or stocks a named medium. Seek urgent care for relevant warning signs: Unexpected severe pain, heavy bleeding, faintness or breathing difficulty after a procedure needs urgent clinical care.

Before booking the next procedure, send the treating clinician the question you want answered and the reports that might answer it. Ask for a one-page plan covering what is known, what needs checking, which visits are essential, who gives instructions for medicines and whom to contact if symptoms change. Request the total cost in writing and a separate explanation of optional items. This preserves decision quality while avoiding unnecessary journeys. Ask specifically how this medium is introduced during the transfer-day workflow. If the facility says there is no opt-out because the medium is standard, request a transparent explanation rather than assuming a hidden charge. Whether the patient can meaningfully choose an alternative depends on the laboratory’s validated process and consent approach.